We are live on ! Find out more
MCMC

Matrix Capital Management Company Portfolio holdings

AUM $46.3M
1-Year Est. Return 114.38%
This Fund
S&P 500
This Quarter Est. Return
+20.64%
1 Year Est. Return
+114.38%
3 Year Est. Return
+245.06%
5 Year Est. Return
+259.19%
10 Year Est. Return
+1,887.32%
AUM
$8.61B
AUM Growth
+$1.24B
Cap. Flow
-$40.9M
Cap. Flow %
-0.48%
Top 10 Hldgs %
91.37%
Holding
20
New
3
Increased
2
Reduced
2
Closed
1

Sector Composition

Rank Sector Weight
1 Technology 70.28%
2 Industrials 11.38%
3 Consumer Discretionary 11.11%
4 Healthcare 6.7%
5 Materials 0.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NVDA icon
1
NVIDIA
NVDA
$4.73T
$1.34B 15.55%
31,637,000
-22,509,000
-42% -$747M
GFS icon
2
GlobalFoundries
GFS
$26.9B
$1.1B 12.79%
17,048,000
-800,000
-4% -$48.4M
AMAT icon
3
Applied Materials
AMAT
$366B
$1.02B 11.84%
7,052,700
+755,000
+12% +$94.5M
TDG icon
4
TransDigm Group
TDG
$71.8B
$979M 11.38%
1,094,900
AMZN icon
5
Amazon
AMZN
$2.5T
$956M 11.11%
7,335,828
ALTR
6
DELISTED
Altair Engineering Inc
ALTR
$847M 9.85%
11,174,200
MRVL icon
7
Marvell Technology
MRVL
$156B
$510M 5.93%
+8,532,697
New +$415M
ZNTL icon
8
Zentalis Pharmaceuticals
ZNTL
$335M
$394M 4.58%
13,959,973
+4,760,000
+52% +$114M
ASML icon
9
ASML
ASML
$613B
$360M 4.19%
497,200
WDAY icon
10
Workday
WDAY
$41.9B
$358M 4.16%
1,586,043
SNPS icon
11
Synopsys
SNPS
$73.8B
$265M 3.08%
609,735
QCOM icon
12
Qualcomm
QCOM
$172B
$222M 2.57%
+1,861,000
New +$214M
ADPT icon
13
Adaptive Biotechnologies
ADPT
$3.6B
$77.7M 0.9%
11,572,590
AURA icon
14
Aura Biosciences
AURA
$731M
$66.2M 0.77%
5,362,870
PRM icon
15
Perimeter Solutions
PRM
$5.72B
$45.9M 0.53%
7,462,500
ADAP
16
DELISTED
Adaptimmune Therapeutics
ADAP
$36.1M 0.42%
38,974,185
ADSK icon
17
Autodesk
ADSK
$52.4B
$24.3M 0.28%
+119,000
New +$23.8M
VTYX
18
DELISTED
Ventyx Biosciences
VTYX
$2.95M 0.03%
89,900
ZS icon
19
Zscaler
ZS
$25.2B
$2.69M 0.03%
18,405
XLE icon
20
State Street Energy Select Sector SPDR ETF
XLE
$39.1B
-2,564,000
Closed -$106M

Similar funds

Matrix Capital Management Company's Q2 2023 Portfolio in Review

As of Q2 2023, Matrix Capital Management Company held 20 positions worth $8.61B, up 17% from $7.36B the previous quarter. Its ten largest holdings account for 91% of the portfolio.

Matrix Capital Management Company's Q2 2023 filing shows 3 new, 2 increased, 2 reduced and 1 closed positions. Its largest new stake was Marvell Technology: 8,532,697 shares worth $510M. The largest sale was NVIDIA, an estimated $747M.

By sector, the portfolio is most concentrated in Technology at 70% of assets, down from 72% a quarter earlier, followed by Industrials and Consumer Discretionary.

  • Matrix Capital Management Company's largest Q2 2023 buy was Marvell Technology: 8,532,697 shares worth $510M.
  • Matrix Capital Management Company added most to Zentalis Pharmaceuticals in Q2 2023, an estimated $114M increase.
  • Matrix Capital Management Company's biggest Q2 2023 reduction was NVIDIA, cutting an estimated $747M.
  • Matrix Capital Management Company fully exited State Street Energy Select Sector SPDR ETF in Q2 2023, selling an estimated $106M.
  • Matrix Capital Management Company's ten largest holdings make up 91% of its $8.61B portfolio in Q2 2023.
  • Matrix Capital Management Company opened 3 new positions and closed 1 in Q2 2023.
  • Matrix Capital Management Company's portfolio value rose 17% quarter-over-quarter to $8.61B.

Based on Matrix Capital Management Company's 13F filing for Q2 2023, filed 14 Aug 2023.